ABSTRACT
INTRODUCTION
Various studies suggest that approximately 150 million people suffer from diabetes the world over, and that this number may well double by the year 2025 (1) . One fifth of the diabetics will be from India. Much of this increase will occur in developing countries and could be due to population growth, ageing, unhealthy diets, obesity and sedentary lifestyles.
Paulose et al predict that by 2025 there will be 195 % increase in the number of diabetics in India (2) . Oral medication is initiated in Type 2 diabetics when 2 -3months of diet and exercise alone are unable to achieve or maintain their optimal plasma glucose levels. These drugs are easy to use but they have shown to have adverse effects (2, 3) . Currently enormous research interest is centered world wide about the search for newer, cheaper, and safer herbal based formulations which can effectively normalize the metabolic derangement underlying the onset of clinical diabetes. Recent scientific investigations have confirmed the efficacy of many of the ayurvedic preparations, some of which are remarkably effective, relatively nontoxic and have substantial documentation of efficacy (2, 4) .
In this scenario, we took up a challenging study to evaluate the clinical efficacy of an ayurvedic antidiabetic drug "Rajanyamalakadi" (Mfd. By Bipha Drug Laboratories, Kottayam).
MATERIALS AND METHODS
Diabetic patients who were willing to participate in the study were invited for a free medical camp at the District Ayurveda Hospital, Ernakulam . An informed consent for the study was obtained from each patient and the patients were given a code number which was found to be helpful through out the course of the study. The clinical proforma was given to each patient to collect data such as height, weight, diet pattern, previous history of illness etc. Diets of all groups consisted of whole wheat chappathi (4-6daily), half a plate unpolished rice or idli with side dishes of potatoes, peas, tomatoes, beans, lean meat, fish and skimmed milk daily as formulated by a dietician for non vegetarians and without meat and fish for vegetarians. The ongoing antidiabetic medications were stopped under medical supervision and were provided "Rajanyamalakadi" tablets.
INGREDIENTS OF THE DRUG
Rajanyamalakadi, contains the time tested antidiabetic extracts from Salacia oblonga, Curcuma longa and Emblica officinalis. Each Tablet of 500 mg contains: Salacia oblonga wall-250 mg, Curcuma longa L-125 mg, Emblica officinalis-125 mg.
Salacia oblonga:
In traditional Indian medicine the root bark of S.oblonga is used in gonnorhoea, rheumatism and skin diseases (5,6). Augusti et al (7, 8) isolated an active terpenoid fraction from the root bark of this plant and showed its antidiabetic action in normal and Streptozotocin diabetic rats. The roots and stems of Salacia reticulata also contain potent antidiabetic chemical constituents. Mangiferin (9) ( a xanthone from the roots) and sulfonium ion derivatives, kotalanol (10) and salacinol(from the roots and stems) (11) , have been identified as the antidiabetic principles. Mangiferin also inhibits aldose reductase activity, thereby delaying the onset or progression of diabetic complications. ( eg: diabetic neuropathy and nephropathy). It is possible that these components of S.reticulata could also be present in S.oblonga. However for these studies are warranted. The polyphenol constituents of S.oblonga, the catechins, also contribute to the antidiabetic property of the plant (5).
Curcuma longa:
The active principles in the rhizome of this plant viz; curcuminoids lower lipid peroxidation by maintaining the activities of antioxidant enzymes like superoxide dismutase, catalase and glutathione peroxidase at higher levels. Antioxidant properties of curcuma longa is due to curcumin and its three derivatives (demethoxy curcumin, bisdemethoxy curcumin and diacetyl curcumin) (12, 13) .
Emblica officinalis: Shows pronounced antioxidant properties. The antioxidant and antidiabetic properties have recently been attributed to the tannoid complexes (14) , epigallocatechin gallate, emblican a, emblicanin b, punigluconin and pedunculagin. Emblica officinalis also shows significant hypolipidemic activity in combination with curcuma longa, it is effective in the long term treatment of diabetes (15) . Jose and Kuttan (16) studied the antioxidant activities of E.officinalis and its active ingredients are aqueous soluble, but partially extractable with ether and are heat stable. According to many the active components in the E.officinalis are ascorbic acid, tannins, trigalloylglucose, flavonoids etc. Polyphenols are ellagic acid and phyllemblic acid (15, 16) .
The dosage of the drug was decided by the supervising medical officer on a case to case basis, taking note of the clinical conditions and responsiveness of the patient. A log book was maintained for each of the patients. The patients were monitored for 3 months. The patients were divided into 6 groups based on their age group and also according to the mean FBS values. As control group normal healthy subjects of the age group 35 -75 were taken. After overnight fasting blood parameters were determined.
The Groups are as follows: Group I -Normal Control Subjects (n=10); Group II -35-45 yrs (n=15); Group III -46-55 yrs (n=13); Group IV -> 55 yrs (n=15); Group V -FBS < 145.9 mg/dl (n=21); Group VI -FBS > 145.9 mg/dl (n=22).
Fasting Blood Sugar (FBS) (25) , insulin (26) , glycosylated haemoglobin (gly Hb) (27) , lipid profile (28, 29, 30, 31) , free fatty acids (FFA) (32), atherogenic index (33), glutathione reductase (34), Aspartate amino transferase (AST) and Alanine amino transferase (ALT) (35) , Blood Urea Nitrogen (BUN) (36) and Creatinine (37) were determined according to standard methods in the venous blood prior and after oral administration of the medicine for a period of 3 months. Their mean values were recorded in the tables. Statistical analysis was done using Software package for social sciences (SPSS) (38, 39) . Lowest level of significance was fixed at P < 0.05. Tables 1-4 The result showed that the drug has significant hypoglycemic and hypolipidemic effects without any observable toxicity in the diabetic patients of all age groups studied. These effects of the drug are due to the active principles contained in its ingredients. There are notable variations in the amelioration of parameters according to initial FBS and age range of the diabetic patients studied.
RESULTS

Results are given in
DISCUSSION
As all these ingredients of the drug viz; Salacia oblonga, Curcuma longa and Emblica officinalis contain various nutraceuticals such as terpenoids, curcuminoids and polyphenols/flavonoids respectively, they are all endowed with biological effects such as antioxidant, antidiabetic, immunomodulatory and hypolipidemic properties. As per the P < 0.001 P < 0.001 P < 0.001 P < 0.001 NS P < 0.001
Level of significance between groups is determined from initial and final values. All values except that with astrics are significant work of Augusti et al (7, 8) , S.oblonga contains a terpenoid and a polysaccharide with antidiabetic effects. This and similar properties of the S.oblonga compounds might have made the drug under study a strong antidiabetic agent. In two previous reports E.officinalis extract has been shown to reduce liver injury caused by administration of xenobiotics, to ameliorate conditions of atherosclerosis and diabetes (16, 17) . Moreover E.officinalis extracts are found to reduce the toxicity and clastogenicity induced by heavy metals also (18) . E.officinalis polyphenols and C.longa curcuminoids, with their antioxidant and hypolipidemic properties (14, 19) could protect the β−cells of pancreas from oxidative stress and make them properly functional, with the added advantage of modulating the lipid profile. The drug combinations with Salacia oblonga and such other plants as above could minimize long term diabetic complications also (20) . Hence the drug "Rajanyamalakadi" is a three in one combination of several nutraceuticals and their mechanism of action may be through stimulation of insulin secretion (21), antioxidant (22) , hypolipidemic, antidiabetic (23, 24) , hepatoprotective (40) and various such other actions as reported by several workers from time to time for curcuma longa and other plant products. The lowering of blood sugar, serum lipids and amelioration of serum insulin level by the biological actions of the various nutraceuticals in the drug might have protected the liver from various stressful conditions also, eg. decrease in the mechanisms of detoxifications, chances of fatty liver, fall in protein and enzyme synthesis etc. A balanced condition of these activities might have helped the treated diabetics to ameliorate the ups and downs of serum parameters such as marker enzymes like ALT, AST and glutathione reductase for liver and heart diseases respectively. We should appreciate the wisdom of Bipha Drug Laboratories Limited for the preparation of this drug for the benefit of type II diabetics who form a major chunk of India's cream society.
Mechanism of action of the neutraceuticals present in the components of the drug as suggested by various workers. As the serum insulin level of the treated patients increased significantly some of these compounds might have acted as insulin secretagogues, viz ; Terpenoids of S.oblonga wall and polyphenols of Emblica officinalis. Most of the active compounds present in the drugs are antioxidants and they must have protected the cells and increased their sensitivity to glucose and insulin viz ; polyphenols and flavonoids in E.officinalis, the terpenoids of S.oblonga and curcumin of turmeric. This type of amelioration in diabetic condition of the patients might have improved the synthesis and activities of the enzymes that control carbohydrate, protein and lipid metabolism viz ; antioxidant curcuminoids, terpenoids, polphenols, flavonoids etc in the drug are responsible for this. As a combined effect of the above actions for three months, diabetes was controlled in the patients with accompanying improvement in all its aspects of the blood parameters.
ACKNOWLEDGMENT
We gratefully acknowledge the help obtained from the Medical officers of the District Ayurvedic Hospital, Ernakulam for their co-operation in conductions and completion of this work. We also express sincere thanks to Bipha drug laboratories, Kottayam for Providing Medicines and partial financial assistance for the completion of this study. 
